Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
01 nov. 2024 18h51 HE
|
Recor Medical
Palo Alto, CA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced U.S. Centers for...
Recor Medical Responds to the American Heart Association’s (AHA) Scientific Statement on Renal Denervation for the Treatment of Hypertension
19 août 2024 09h00 HE
|
Recor Medical
Palo Alto, CA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) greatly appreciate the American...
CMS Approves Additional Payment for Recor Medical’s Paradise™ Ultrasound Renal Denervation System in Hospital Inpatient Cases
12 août 2024 09h00 HE
|
Recor Medical
Palo Alto, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced today that the Centers...
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension with Ultrasound Renal Denervation
25 juil. 2024 10h00 HE
|
Recor Medical
Palo Alto, CA, July 25, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the first patients...
Recor Medical Champions Global Action on World Hypertension Day: Early Intervention and Continued Innovation Crucial in Tackling This Silent Killer Impacting Billions Worldwide
17 mai 2024 09h00 HE
|
Recor Medical
Palo Alto, CA, May 17, 2024 (GLOBE NEWSWIRE) -- Hypertension, or high blood pressure, affects nearly half of all Americans and more than one billion people worldwide. Hypertension is known as the...
Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United Arab Emirates
18 avr. 2024 11h00 HE
|
Recor Medical
Palo Alto, CA, April 18, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), announce the first commercial...
Renal Denervation Market: Patient-Centric Care, Set to Exceed USD 50.1 Billion by 2034 with 38.40% Growth – By PMI
19 févr. 2024 19h30 HE
|
PMI
Covina, Feb. 19, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Renal Denervation Market size was valued at about USD 2.6 Billion in 2024 and expected to grow at CAGR of...
Renal Denervation Catheters Industry Pipeline Report, 2023 and Beyond - In-Depth Insights Into the Devices Under Development, Their Clinical Progress, and the Key Companies Shaping the Future
22 janv. 2024 18h58 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ...
Global Renal Denervation Technologies Strategic Research Report 2024
15 janv. 2024 09h23 HE
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Renal Denervation Technologies - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Renal Denervation...
Global Renal Denervation Market Report 2023-2028: Funding Boosts Research and Market Expansion with United States Dominating
13 sept. 2023 04h08 HE
|
Research and Markets
Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Renal Denervation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Technology, By Product, By...